日本調剤(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 小売業 | 3341/E05422 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2014/08/15 | 日証協 | 98,160株 | +1.03% | 19,515株 | +1.44% | 96,164株 | -1.74% | 2,696株 | -58.29% |
| 2014/08/08 | 日証協 | 97,160株 | -1.11% | 19,238株 | +373.61% | 97,871株 | -3.02% | 6,463株 | -44.88% |
| 2014/08/01 | 日証協 | 98,255株 | +12.9% | 4,062株 | +1551.22% | 100,916株 | +12.01% | 11,725株 | +2263.91% |
| 2014/07/25 | 日証協 | 87,025株 | -3.93% | 246株 | -90.49% | 90,099株 | -3.2% | 496株 | -88.38% |
| 2014/07/18 | 日証協 | 90,583株 | +2.6% | 2,588株 | -67.7% | 93,077株 | +4.04% | 4,268株 | +450% |
| 2014/07/11 | 日証協 | 88,287株 | -0.58% | 8,012株 | +17.13% | 89,461株 | +0.15% | 776株 | -91.03% |
| 2014/07/04 | 日証協 | 88,803株 | -3.42% | 6,840株 | -58.44% | 89,331株 | -8.73% | 8,650株 | +198.28% |
| 2014/06/27 | 日証協 | 91,943株 | -11.04% | 16,457株 | +352.12% | 97,871株 | -6.57% | 2,900株 | -74.56% |
| 2014/06/20 | 日証協 | 103,357株 | -11.73% | 3,640株 | -16.78% | 104,751株 | -11.73% | 11,400株 | -13.47% |
| 2014/06/13 | 日証協 | 117,087株 | -3.72% | 4,374株 | -11.71% | 118,671株 | -1.86% | 13,175株 | +129.37% |
| 2014/06/06 | 日証協 | 121,614株 | -9.01% | 4,954株 | -59.15% | 120,914株 | -7.17% | 5,744株 | -44.74% |
| 2014/05/30 | 日証協 | 133,653株 | +3.63% | 12,128株 | +589.09% | 130,250株 | +2.17% | 10,394株 | +982.71% |
| 2014/05/23 | 日証協 | 128,973株 | -4.66% | 1,760株 | -88.6% | 127,486株 | -1.3% | 960株 | -50.26% |
| 2014/05/16 | 日証協 | 135,273株 | +1.88% | 15,432株 | +235.48% | 129,166株 | -0.02% | 1,930株 | -91.66% |
| 2014/05/09 | 日証協 | 132,773株 | +2.46% | 4,600株 | +11.38% | 129,195株 | +2.74% | 23,134株 | +453.44% |
| 2014/05/02 | 日証協 | 129,583株 | +0.02% | 4,130株 | -64.22% | 125,755株 | -0.73% | 4,180株 | -79.83% |
| 2014/04/25 | 日証協 | 129,553株 | -0.04% | 11,542株 | +0.52% | 126,675株 | -0.09% | 20,720株 | -1.99% |
| 2014/04/18 | 日証協 | 129,603株 | -0.69% | 11,482株 | +238.7% | 126,785株 | +0.55% | 21,140株 | +647% |
| 2014/04/11 | 日証協 | 130,503株 | -0.04% | 3,390株 | -77.31% | 126,095株 | +0.33% | 2,830株 | -53.76% |
※株式分割は考慮していませんのでご注意ください。
Page Top